Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
8.05
-0.04 (-0.49%)
Oct 19, 2026, 2:08 PM EDT - Market open
Harvard Bioscience Market Cap
Harvard Bioscience has a market cap or net worth of $36.65 million as of October 19, 2026. It is the 32,552nd most valuable company in the world and the 4,836th biggest in the United States. Its market cap has increased by 116.84% in one year.
Market Cap
36.65M
Enterprise Value
74.35M
1-Year Change
116.84%
Global Rank
Country Rank
#4,836 United States
Category
ChartMarket Cap Chart
Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $36.65M, a decrease of -78.88%. That is a compound annual growth rate of -5.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 36.65M | 22.97% |
| Dec 31, 2025 | 29.80M | -67.61% |
| Dec 31, 2024 | 92.00M | -59.72% |
| Dec 29, 2023 | 228.40M | 97.92% |
| Dec 30, 2022 | 115.40M | -59.89% |
| Dec 31, 2021 | 287.70M | 72.07% |
| Dec 31, 2020 | 167.20M | 44.01% |
| Dec 31, 2019 | 116.10M | -2.11% |
| Dec 31, 2018 | 118.60M | 3.04% |
| Dec 29, 2017 | 115.10M | 9.83% |
| Dec 30, 2016 | 104.80M | -11.04% |
| Dec 31, 2015 | 117.80M | -35.91% |
| Dec 31, 2014 | 183.80M | 26.15% |
| Dec 31, 2013 | 145.70M | 15.45% |
| Dec 31, 2012 | 126.20M | 14.42% |
| Dec 30, 2011 | 110.30M | -4.42% |
| Dec 31, 2010 | 115.40M | 9.70% |
| Dec 31, 2009 | 105.20M | 29.08% |
| Dec 31, 2008 | 81.50M | -42.24% |
| Dec 31, 2007 | 141.10M | -9.96% |
| Dec 29, 2006 | 156.70M | 15.56% |
| Dec 30, 2005 | 135.60M | -3.49% |
| Dec 31, 2004 | 140.50M | -47.56% |
| Dec 31, 2003 | 267.90M | 170.88% |
| Dec 31, 2002 | 98.90M | -62.67% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anbio Biotechnology | 137.38M |
| Stereotaxis | 101.20M |
| Daxor | 58.67M |
| Precision Optics Corporation | 47.40M |
| Nephros | 39.64M |
| Milestone Scientific | 28.97M |
| Retractable Technologies | 17.25M |
| Bionano Genomics | 14.72M |